Daniel Arber to Ribonucleoprotein, U2 Small Nuclear
This is a "connection" page, showing publications Daniel Arber has written about Ribonucleoprotein, U2 Small Nuclear.
Connection Strength
0.187
-
Reclassifying myelodysplastic syndromes: what's where in the new WHO and why. Hematology Am Soc Hematol Educ Program. 2015; 2015:294-8.
Score: 0.126
-
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases. Haematologica. 2024 08 01; 109(8):2525-2532.
Score: 0.061